Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2022, Vol. 54 ›› Issue (3): 511-519. doi: 10.19723/j.issn.1671-167X.2022.03.017

Previous Articles     Next Articles

Epidemiological study on the incidence of inflammatory bowel disease in Yinzhou District, Ningbo City from 2011 to 2020

Bing-jie HE1,Zhi-ke LIU1,Peng SHEN2,Ye-xiang SUN2,Bin CHEN3,Si-yan ZHAN1,4,*(),Hong-bo LIN2,*()   

  1. 1. Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
    2. Yinzhou District Center for Disease Control and Prevention, Ningbo 315199, Zhejiang, China
    3. Ningbo Anorectal Hospital, Ningbo 315048, Zhejiang, China
    4. Institute for Artificial Intelligence, Peking University, Beijing 100191, China
  • Received:2021-11-23 Online:2022-06-18 Published:2022-06-14
  • Contact: Si-yan ZHAN,Hong-bo LIN E-mail:siyan-zhan@bjmu.edu.cn;lin73160@163.com
  • Supported by:
    the Beijing Universities Advanced Discipline Construction(7320200015);the National Natural Science Foundation of China(81973146)

RICH HTML

   

PDF (PC)

Abstract:

Objective: To describe the distribution characteristics of inflammatory bowel disease among permanent residents in Yinzhou District, Ningbo City, and to understand the disease burden and development trend of inflammatory bowel disease in this area. Methods: Using the retrospective cohort design, we collected the registration information of all permanent residents in the residents' health files of the Yinzhou Regional Health Information Platform from 2010 to 2020, and used electronic medical records to follow up their inflammatory bowel disease visits. A one-year wash-out period was set, and the patients who were diagnosed with the primary diagnosis for the first time after one year of registration were re-garded as new cases. The incidence density and 95% confidence interval (CI) of inflammatory bowel disease were estimated by Poisson distribution. Results: From 2011 to 2020, a total of 1 496 427 permanent residents in Yinzhou District were included, of which 729 996 were male (48.78%). The total follow-up person-years were 8 081 030.82, and the median follow-up person-years were 5.41 [interquartile range (IQR): 5.29]. During the study period, there were 1 217 new cases of inflammatory bowel disease, of which males (624 cases, 51.27%) were more than females (593 cases, 48.73%). The total incidence density was 15.06/100 000 person-years (95%CI: 14.23, 15.93). Among all new cases, there were 1 106 cases (90.88%) of ulcerative colitis, with an incidence density of 13.69 per 100 000 person-years (95%CI: 12.89, 14.52); 70 cases (5.75%) of Crohn's disease, with an incidence density of 0.87 per 100 000 person-years (95%CI: 0.68, 1.09); and 41 cases (3.37%) of indeterminate colitis, with an incidence density of 0.51 per 100 000 person-years (95%CI: 0.36, 0.69). The median age of onset of ulcerative colitis was 50.82 years old (IQR: 18.77), with the highest proportion (15.01%) in the 45-49 years group. The incidence density of ulcerative colitis gradually increased with age, reaching a relatively high level in the 45-49 years group (20.53/100 000 person-years; 95%CI: 17.63, 23.78), followed by a slight increase. And the incidence density in the 65-69 years group was the highest (25.44/100 000 person-years; 95%CI: 20.85, 30.75), with a rapid decrease in the 75-79 years group. The median age of onset of Crohn's disease was 44.34 years (IQR: 33.41), with the highest proportion (12.86%) in the 25-29 years group. Due to the small number of new cases of Crohn's disease, the age distribution fluctuated greatly, with peaks both in young and old people. From 2011 to 2020, the incidence density of inflammatory bowel disease in Yinzhou District was at a low level from 2011 to 2013, and showed a rapid upward trend from 2014 to 2016, reaching a peak of 24.62 per 100 000 person-years in 2016 (95%CI: 21.31, 28.30), and slightly decreased in 2017—2020. Conclusion: The incidence density of inflammatory bowel disease in Yinzhou District from 2011 to 2020 was at a relatively high level, and medical institutions and health departments need to pay attention to the burden of disease caused by it.

Key words: Inflammatory bowel disease, Ulcerative colitis, Crohn' s disease, Incidence density, Cohort

CLC Number: 

  • R181.2

Table 1

Demographic characteristics of inflammatory bowel disease patients in permanent residents of Yinzhou District from 2011 to 2020"

Items UC
(n=1 106)		 CD
(n=70)		 IC
(n=41)		 P value IBD
(n=1 217)
Age onset/years, M(IQR) 50.82(18.77) 44.34(33.41) 46.41(28.10) < 0.001 50.50(19.94)
Age group onset/years, n(%) < 0.001
  0-19 3(0.27) 7(10.00) 3(7.32) 13(1.07)
  20-24 17(1.54) 2(2.86) 2(4.88) 21(1.73)
  25-29 46(4.16) 9(12.86) 2(4.88) 57(4.68)
  30-34 71(6.42) 7(10.00) 7(17.07) 85(6.98)
  35-39 88(7.96) 7(10.00) 2(4.88) 97(9.97)
  40-44 129(11.66) 4(5.71) 4(9.76) 137(11.26)
  45-49 166(15.01) 6(8.57) 6(14.63) 178(14.63)
  50-54 151(13.65) 4(5.71) 2(4.88) 157(12.90)
  55-59 125(11.30) 3(4.29) 1(2.44) 129(10.60)
  60-64 124(11.21) 8(11.43) 4(9.76) 136(11.18)
  65-69 99(8.95) 7(10.00) 1(2.44) 107(8.79)
  70-74 53(4.79) 4(5.71) 1(2.44) 58(4.77)
  75-79 15(1.36) 2(2.86) 1(2.44) 18(1.48)
  80-84 13(1.18) 0(0.00) 3(7.32) 16(1.31)
  ≥85 6(0.54) 0(0.00) 2(4.88) 8(0.66)
Gender, n(%) 0.132
  Male 557(50.36) 42(60.00) 25(60.98) 624(51.27)
  Female 549(49.64) 28(40.00) 16(39.02) 593(48.73)
Calendar year onset, n(%) < 0.001
  2011 20(1.81) 1(1.43) 2(4.88) 23(1.89)
  2012 6(0.54) 1(1.43) 0(0.00) 7(0.58)
  2013 19(1.72) 2(2.86) 0(0.00) 21(1.73)
  2014 96(8.68) 1(1.43) 1(2.44) 98(8.05)
  2015 144(13.02) 8(11.43) 14(34.15) 166(13.64)
  2016 184(16.64) 3(4.29) 11(26.83) 198(16.27)
  2017 134(12.12) 10(14.29) 2(4.88) 146(12.00)
  2018 176(15.91) 10(14.29) 2(4.88) 188(15.45)
  2019 181(16.37) 20(28.57) 3(7.32) 204(16.76)
  2020 146(13.20) 14(20.00) 6(14.63) 166(13.64)

Figure 1

Incidence density of ulcerative colitis by gender and age group in Yinzhou District"

Figure 2

Incidence density of Crohn's disease by gender and age group in Yinzhou District"

Figure 3

Time distribution of inflammatory bowel disease incidence density in Yinzhou District from 2011 to 2020 UC, ulcerative colitis; CD, Crohn's disease; IBD, inflammatory bowel disease."

Figure 4

Age distribution of inflammatory bowel disease incidence density in Yinzhou District from 2011 to 2020"

1 葛均波, 徐永健. 内科学[M]. 8版 北京: 人民卫生出版社, 2013: 385- 393.
2 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2012年·广州)[J]. 胃肠病学, 2012, 17 (12): 763- 781.
doi: 10.3969/j.issn.1008-7125.2012.12.013
3 张玉洁, 梁洁, 吴开春. 炎症性肠病诊断与治疗的共识意见(2018年, 北京)溃疡性结肠炎部分解读[J]. 中华消化杂志, 2018, 38 (5): 312- 314.
doi: 10.3760/cma.j.issn.0254-1432.2018.05.003
4 Ungaro R , Mehandru S , Allen PB , et al. Ulcerative colitis[J]. Lancet, 2017, 389 (10080): 1756- 1770.
doi: 10.1016/S0140-6736(16)32126-2
5 冉志华, 童锦禄. 炎症性肠病诊断与治疗的共识意见(2018年, 北京)克罗恩病部分解读[J]. 中华消化杂志, 2018, 38 (5): 315- 317.
doi: 10.3760/cma.j.issn.0254-1432.2018.05.004
6 Torres J , Mehandru S , Colombel JF , et al. Crohn's disease[J]. Lancet, 2017, 389 (10080): 1741- 1755.
doi: 10.1016/S0140-6736(16)31711-1
7 Alatab S , Sepanlou SG , Ikuta K , et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990—2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol, 2020, 5 (1): 17- 30.
doi: 10.1016/S2468-1253(19)30333-4
8 李学锋, 彭霞, 周明欢. 我国炎症性肠病流行病学研究进展[J]. 现代消化及介入诊疗, 2020, 25 (9): 1265- 1267.
doi: 10.3969/j.issn.1672-2159.2020.09.032
9 Qiu Y , Ren W , Liu Y , et al. Disease burden of inflammatory bowel disease in China from 1990 to 2017: findings from the Glo-bal Burden of Diseases 2017[J]. E Clin Med, 2020, 27, 100544.
10 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见(2018年·北京)[J]. 中华炎性肠病杂志, 2018, 2 (3): 173- 190.
doi: 10.3760/cma.j.issn.2096-367X.2018.03.005
11 Cui G , Yuan A . A systematic review of epidemiology and risk factors associated with Chinese inflammatory bowel disease[J]. Front Med, 2018, 5, 183.
doi: 10.3389/fmed.2018.00183
12 Li X , Song P , Li J , et al. The disease burden and clinical characteristics of inflammatory bowel disease in the Chinese population: a systematic review and meta-analysis[J]. Int J Environ Res Public Health, 2017, 14 (3): 238.
doi: 10.3390/ijerph14030238
13 Qiao Y , Ran Z . Potential influential factors on incidence and pre-valence of inflammatory bowel disease in mainland China[J]. JGH Open, 2019, 4 (1): 11- 15.
14 Huang K , Tao S , Zhou X , et al. Incidence rates of health outcomes of interest among Chinese children exposed to selected vaccines in Yinzhou Electronic Health Records: a population-based retrospective cohort study[J]. Vaccine, 2020, 38 (18): 3422- 3428.
doi: 10.1016/j.vaccine.2020.03.013
15 鄞州区普查中心. 鄞州区人口普查公报数据解读[EB/OL]. (2021-05-19)[2021-11-22]. http://www.nbyz.gov.cn/art/2021/5/19/art_1229108054_59071135.html.
16 林鸿波, 刘翠丽, 沈鹏, 等. 基于鄞州区域医疗数据的利巴韦林临床使用的分析[J]. 中国药物警戒, 2018, 15 (2): 73- 77.
doi: 10.3969/j.issn.1672-8629.2018.02.003
17 Yang Y , Zhou X , Gao S , et al. Evaluation of electronic healthcare databases for post-marketing drug safety surveillance and pharmacoepidemiology in China[J]. Drug Saf, 2018, 41 (1): 125- 137.
doi: 10.1007/s40264-017-0589-z
18 浙江省人民政府. 浙江省人民政府关于调整宁波市部分行政区划的通知[EB/OL]. (2016-09-30)[2021-11-22]. http://www.zj.gov.cn/art/2016/9/30/art_1229017138_64597.html.
19 Keyashian K , Dehghan M , Sceats L , et al. Comparative incidence of inflammatory bowel disease in different age groups in the United States[J]. Inflamm Bowel Dis, 2019, 25 (12): 1983- 1989.
doi: 10.1093/ibd/izz092
20 Jung YS , Han M , Kim WH , et al. Incidence and clinical outcomes of inflammatory bowel disease in South Korea, 2011—2014: a nationwide population-based study[J]. Dig Dis Sci, 2017, 62 (8): 2102- 2112.
doi: 10.1007/s10620-017-4640-9
21 Kaplan GG , Windsor JW . The four epidemiological stages in the global evolution of inflammatory bowel disease[J]. Nat Rev Gastroenterol Hepatol, 2021, 18 (1): 56- 66.
doi: 10.1038/s41575-020-00360-x
22 Zeng Z , Zhu Z , Yang Y , et al. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study[J]. J Gastroenterol Hepatol, 2013, 28 (7): 1148- 1153.
doi: 10.1111/jgh.12164
23 Yang H , Li Y , Wu W , et al. The incidence of inflammatory bowel disease in Northern China: a prospective population-based study[J]. PLoS One, 2014, 9 (7): e101296.
doi: 10.1371/journal.pone.0101296
24 Zhao J , Ng SC , Lei Y , et al. First prospective, population-based inflammatory bowel disease incidence study in mainland of China: the emergence of "Western" disease[J]. Inflamm Bowel Dis, 2013, 19 (9): 1839- 1845.
25 Ng SC , Tang W , Ching JY , et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn' s and colitis epidemiology study[J]. Gastroenterology, 2013, 145 (1): 158- 165.
doi: 10.1053/j.gastro.2013.04.007
26 缪佳蓉. 云南省炎症性肠病流行病学特征、环境及复发因素的研究[D]. 云南: 昆明医科大学, 2015.
27 Shivashankar R , Tremaine WJ , Harmsen WS , et al. Incidence and prevalence of Crohn's disease and ulcerative colitis in Olms-ted County, Minnesota from 1970 through 2010[J]. Clin Gastroenterol Hepatol, 2017, 15 (6): 857- 863.
doi: 10.1016/j.cgh.2016.10.039
28 Kotze PG , Underwood FE , Damião A , et al. Progression of inflammatory bowel diseases throughout Latin America and the Caribbean: a systematic review[J]. Clin Gastroenterol Hepatol, 2020, 18 (2): 304- 312.
doi: 10.1016/j.cgh.2019.06.030
29 Burisch J , Munkholm P . The epidemiology of inflammatory bowel disease[J]. Scand J Gastroenterol, 2015, 50 (8): 942- 951.
doi: 10.3109/00365521.2015.1014407
30 Mak WY , Zhao M , Ng SC , et al. The epidemiology of inflammatory bowel disease: east meets west[J]. J Gastroenterol Hepatol, 2020, 35 (3): 380- 389.
doi: 10.1111/jgh.14872
31 Loftus EV Jr. , Silverstein MD , Sandborn WJ , et al. Ulcerative colitis in Olmsted County, Minnesota, 1940—1993: incidence, prevalence, and survival[J]. Gut, 2000, 46 (3): 336- 343.
doi: 10.1136/gut.46.3.336
32 浙江统计数据库. 鄞州区地区生产总值统计[EB/OL]. (2021-02-22)[2021-10-22]. http://data.tjj.zj.gov.cn/page/dataquery.simpleMacro/newQuery/newQuery.jsp?getData=nianduData&ddiUrn=urn:ddi:ZJJCKSTAT:a463a4d9-806b-4fcc-8fc9-b43a8ee4298c:1&dataClassific=yandu&sjztId=urn:ddi:ZJJCKSTAT:8c1a842d-cf0b-40b5-b355-ec4c8d90c506:1&sjztB-gq=N&orgCode=330212&proDemo=zj.
33 浙江统计数据库. 鄞州区人均生产总值统计[EB/OL]. (2021-02-22)[2021-10-22]. http://data.tjj.zj.gov.cn/page/dataquery.simpleMacro/newQuery/newQuery.jsp?getData=nianduData&ddiUrn=urn:ddi:ZJJCKSTAT:a463a4d9-806b-4fcc-8fc9-b43a8ee4298c:1&dataClassific=yandu&sjztId=urn:ddi:ZJJCKSTAT:8c1a842d-cf0b-40b5-b355-ec4c8d90c506:1&sjztB-gq=N&orgCode=330212&proDemo=zj.
34 Chen Y . Perspectives of IBD China: is Crohn's and colitis foundation model a solution to health care issues for the country?[J]. Inflamm Bowel Dis, 2018, 24 (5): 925- 929.
doi: 10.1093/ibd/izy056
35 Ng SC , Shi HY , Hamidi N , et al. Worldwide incidence and pre-valence of inflammatory bowel disease in the 21st century: a syste-matic review of population-based studies[J]. Lancet, 2017, 390 (10114): 2769- 2778.
doi: 10.1016/S0140-6736(17)32448-0
[1] Zhihan YUE,Na HAN,Zheng BAO,Jinlang LYU,Tianyi ZHOU,Yuelong JI,Hui WANG,Jue LIU,Haijun WANG. A prospective cohort study of association between early childhood body mass index trajectories and the risk of overweight [J]. Journal of Peking University (Health Sciences), 2024, 56(3): 390-396.
[2] Huichao MA,Jun LI,Yongqing WANG. Clinical characteristics of pregnancy complicated with inflammatory bowel disease [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 260-266.
[3] Xiaoqiang LIU,Yin ZHOU. Risk factors of perioperative hypertension in dental implant surgeries with bone augmentation [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 93-98.
[4] Huan YU,Ruo-tong YANG,Si-yue WANG,Jun-hui WU,Meng-ying WANG,Xue-ying QIN,Tao WU,Da-fang CHEN,Yi-qun WU,Yong-hua HU. Metformin use and risk of ischemic stroke in patients with type 2 diabetes: A cohort study [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 456-464.
[5] Tao MA,Yan-hui LI,Man-man CHEN,Ying MA,Di GAO,Li CHEN,Qi MA,Yi ZHANG,Jie-yu LIU,Xin-xin WANG,Yan-hui DONG,Jun MA. Associations between early onset of puberty and obesity types in children: Based on both the cross-sectional study and cohort study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 961-970.
[6] LIU Jie,GUO Chao. A prospective cohort study of the influence of positive/negative effectivity on the mortality risk of the Chinese elderly [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 255-260.
[7] YAO Xiao-ying,LIU Zhi-ke,LI Ning,MA Rui,ZHAO Xue-fei,ZHANG Liang,XU Guo-zhang,ZHAN Si-yan,FANG Ting. Epidemiological study of infantile epilepsy incidence density among infants under 36 months of age in Ningbo City from 2015 to 2019 [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 485-490.
[8] LIU Xiao-qiang,YANG Yang,ZHOU Jian-feng,LIU Jian-zhang,TAN Jian-guo. Blood pressure and heart rate changes of 640 single dental implant surgeries [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 390-395.
[9] Huan LIU,Ying-dong HE,Jin-bo LIU,Wei HUANG,Na ZHAO,Hong-wei ZHAO,Xiao-hua ZHOU,Hong-yu WANG. Predictive value of vascular health indicators on newly cardiovascular events: Preliminary validation of Beijing vascular health stratification system [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 514-520.
[10] Wen-ying MENG,Wan-tong HUANG,Jie ZHANG,Ming-yuan JIAO,Lei JIN,Lei JIN. Relationship between serum vitamin E concentration in first trimester and the risk of developing hypertension disorders complicating pregnancy [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 470-478.
[11] Xun TANG,Du-dan ZHANG,Xiao-fei LIU,Qiu-ping LIU,Yang CAO,Na LI,Shao-ping HUANG,Hui-dong DOU,Pei GAO,Yong-hua HU. Application of the China-PAR stroke risk equations in a rural northern Chinese population [J]. Journal of Peking University (Health Sciences), 2020, 52(3): 444-450.
[12] Jun LI,Zhan-yue NIU,Yan XUE,Xue-ying SHI,Bo ZHANG,Yuan WANG. Kaposi sarcoma combined with severe ulcerative colitis: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2020, 52(2): 373-377.
[13] Ting-ting WANG,Ying HAN,Fang-fang GAO,Lei YE,Yu-jun ZHANG. Effects of circular RNA circ-SOD2 on intestinal epithelial barrier and ulcerative colitis [J]. Journal of Peking University(Health Sciences), 2019, 51(5): 805-812.
[14] LIN Hong-bo, CHEN Yi, SHEN Peng, LI Xiao-yong,SI Ya-qin, ZHANG Du-dan, TANG Xun, GAO Pei. Incidence and risk factors of chronic kidney disease in community-based patients with diabetes [J]. Journal of Peking University(Health Sciences), 2018, 50(3): 416-421.
[15] YANG Yu, ZHAO Hou-yu, ZHAN Si-yan. Necessity and feasibility of data sharing of cohort studies#br# #br# [J]. Journal of Peking University(Health Sciences), 2018, 50(2): 381-385.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd